Signaling pathways
-
F1793 Anti-VEGFC Antibody (VGX100)Summary: Anti-VEGFC Antibody (VGX100) -
F1794 Anti-VEGF Antibody (Varisacumab)Summary: Anti-VEGF Antibody (Varisacumab) -
F1795 Anti-TGFb1 Antibody (SRK181)Summary: Anti-TGFb1 Antibody (SRK181) -
F1796 Anti-158P1D7 Antibody (Agensys patent anti-158P1D7)Summary: Anti-158P1D7 Antibody (Agensys patent anti-158P1D7) -
F1797 Anti-VEGFR2/KDR/CD309 Antibody (Imclone 6.64)Summary: Anti-VEGFR2/KDR/CD309 Antibody (Imclone 6.64) -
F1798 Anti-VEGFR3/FLT4 Antibody (LY3022856)Summary: Anti-VEGFR3/FLT4 Antibody (LY3022856) -
F1799 Anti-TNFRSF17/BCMA/CD269 Antibody (Belantamab mafodotin)Summary: Anti-TNFRSF17/BCMA/CD269 Antibody (Belantamab mafodotin) -
F1800 Anti-NAMPT Antibody (Alt-100)Summary: Anti-NAMPT Antibody (Alt-100) -
F1801 Anti-KIR2DL1/CD158a Antibody (Innate patent anti-KIR2DL)Summary: Anti-KIR2DL1/CD158a Antibody (Innate patent anti-KIR2DL) -
F1802 Anti-LIF Antibody (MSC-1)Summary: Anti-LIF Antibody (MSC-1)